GSK-3494245

N/A

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameGSK-3494245
Drug Alias NameGSK-3494245DDD-1305143
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProteasome inhibitors
TargetsProteasome
Therapy Area/IndicationsLeishmaniasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsLeishmaniasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A